Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:NPD

(NPD) (NPD) Stock Price, News & Analysis

(NPD) logo

About (NPD) Stock (NYSE:NPD)

Key Stats

Today's Range
$2.55
$2.55
50-Day Range
N/A
52-Week Range
$2.00
$2.59
Volume
N/A
Average Volume
61,544 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NPD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (NPD) and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NPD Stock News Headlines

Trump’s AI Agenda: The 9 stocks poised to benefit most
While many are busy chasing the usual AI trends, a bigger opportunity is quietly brewing—and most are missing it. Imagine a major shift in how and where AI is built, opening up incredible wealth opportunities for those in the know. I’ve found 9 AI companies primed to lead this change. These aren’t the tired “AI hype” stocks; they’re companies with real US operations, proven revenue growth, and deep AI integration.tc pixel
Natchitoches man arrested for drug offenses
See More Headlines

NPD Stock Analysis - Frequently Asked Questions

(NPD) (NYSE:NPD) released its quarterly earnings data on Wednesday, November, 25th. The company reported $0.00 EPS for the quarter. The business earned $124.77 million during the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that (NPD) investors own include Inovio Pharmaceuticals (INO), Avid Bioservices (CDMO), Corcept Therapeutics (CORT), Cardiome Pharma (CRME), CTI BioPharma (CTIC) and Sprott Focus Trust (FUND).

Company Calendar

Last Earnings
11/25/2015
Today
9/29/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NYSE:NPD
CIK
1414850
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NYSE:NPD) was last updated on 9/29/2025 by MarketBeat.com Staff
From Our Partners